Immunotherapy for head and neck squamous cell carcinoma: A review of current and emerging therapeutic options

Jessica M. Moskovitz, Jennifer Moy, Tanguy Y. Seiwert, Robert L. Ferris

Research output: Contribution to journalReview articlepeer-review

Abstract

Advances in the field of cancer immunotherapy have occurred rapidly over the past decade. Exciting results from clinical trials have led to new treatment options and improved survival for patients with a myriad of solid tumor pathologies. However, questions remain unanswered regarding duration and timing of therapy, combination regimens, appropriate biomarkers of disease, and optimal monitoring of therapeutic response. This article reviews emerging immunotherapeutic agents and significant clinical trials that have led to advancements in the field of immuno-oncology for patients with head and neck squamous cell carcinoma.

Original languageEnglish (US)
Pages (from-to)680-693
Number of pages14
JournalOncologist
Volume22
Issue number6
DOIs
StatePublished - Jun 2017
Externally publishedYes

Keywords

  • Head and neck squamous cell carcinoma
  • Immunotherapy
  • Lymphocyte
  • Neoplasm of head and neck

ASJC Scopus subject areas

  • Oncology
  • Cancer Research

Fingerprint

Dive into the research topics of 'Immunotherapy for head and neck squamous cell carcinoma: A review of current and emerging therapeutic options'. Together they form a unique fingerprint.

Cite this